The global blood screening market is booming, projected to reach [estimated 2033 market size] by 2033, fueled by rising infectious disease prevalence and technological advancements in NAT, ELISA, CLIA, and NGS. Discover key trends, leading companies (Becton Dickinson, Roche, etc.), and regional insights in this comprehensive market analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.